Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
c decrease » c decreased (Expand Search), a decrease (Expand Search), rc decreased (Expand Search)
-
1
-
2
-
3
-
4
Loss of C9orf72 decreases mTOR activation.
Published 2016“…C9orf72-/- MEF cells show a decrease in p-S6K1 when compared with wild-type cells. …”
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Decreased cell stiffness after dissociation of intercellular adhesion.
Published 2014“…<p>HaCaT cells were cultured in calcium-containing medium for 4 days until reaching confluence (<b>A1, B1, C1</b>), and then calcium-depleted for 2 days (<b>A2, B2, C2</b>), or calcium-depleted for 2 days and then reconstituted in calcium-containing medium for another 2 days (<b>A3, B3, C3</b>). …”
-
12
Astrocytic AQP4 is decreased in aged cortical astrocytes.
Published 2015“…<p>(A) AQP4 immunoreactivity (blue) and protein levels (B) are significantly decreased in the aged cortex. …”
-
13
Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant.
Published 2017“…The mean ± SEM rate of Suc-LLVY-AMC cleavage is decreased in the <i>myc-rpt6-S119A</i> mutant compared to the WT and <i>myc-rpt6-S119D</i> strains. …”
-
14
-
15
-
16
<i>roh</i> mutation results in Rh1 decrease.
Published 2015“…<p>(A) GFP fluorescence of one-day old wild-type (left panel) and <i>roh</i><sup><i>EY04039</i></sup> (right panel) flies showing a reduction in Rh1-GFP. Scale bar, 50 μm. (B) Western blotting showing decreased Rh1 levels in the <i>roh</i><sup><i>EY04039</i></sup> mutant (<i>ey-flp Rh1</i>::<i>GFP; FRT42D roh</i><sup><i>EY04039</i></sup><i>/ FRT42D GMR-hid CL</i>); the INAD and TRP levels are not affected compared to the wild-type. …”
-
17
-
18
-
19
Viability of microencapsulated FP ICCs decreased with time post-transplantation.
Published 2013“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. B) Viability decreased with time post-transplantation. Values are mean ± SEM (n = 100 microcapsules/mice for each time point); *p<0.05 viability for days 7 to 21 when compared to pre-transplantation control and days 1 and 3 post-transplantation; #p<0.05 viability for days 14 and 21 when compared to day 7 post-transplantation (one-way ANOVA with post-hoc Tukey-Kramer Multiple-Comparison test).…”
-
20